Comments

CytomX Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does CytomX Therapeutics (CTMX) operate in?

CytomX Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

CTMXNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Q1 2025 Earnings were released on Mon May 12th, before the market open

The most recent conference call was at 17:00 PM, 3 days ago Click to view past webcast

CytomX Therapeutics (CTMX) Forecast

News Earnings CytomX Therapeutics (CTMX) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

CytomX Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CTMX | Benzinga

Explore CytomX Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CTMX.

Open	$2.50
Close	-
Volume / Avg.	3.70M / 4.69M
Day Range	$2.07 - $2.50
52 Wk Range	0.40 - 2.55
Market Cap	$172.21M
P/E Ratio	6.26
Dividend Yield	-
Exchange	NASDAQ
RSI	72
Short Interest	12.25%
Days to Cover	6.96

Recent News

This CytomX Therapeutics Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday

Avi Kapoor

Nano-Cap CytomX Therapeutics Stock Surges On Heels Of Cancer Data Report

CytomX reported early Phase 1 data for CX-2051 in advanced colorectal cancer, with a 94% disease control rate.

Vandana Singh

Why Gap Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.50
Close	-
Volume / Avg.	3.70M / 4.69M
Day Range	$2.07 - $2.50
52 Wk Range	0.40 - 2.55
Market Cap	$172.21M
P/E Ratio	6.26
Dividend Yield	-
Exchange	NASDAQ
RSI	72
Short Interest	12.25%
Days to Cover	6.96

About CytomX Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing nove...

Got Questions? Ask

Analyze CTMX's financials

What is CTMX's 200-day MA?

How has CTMX's EPS changed?

What is CTMX's free cash flow?

What is CTMX's gross margin?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy CytomX Therapeutics (CTMX) stock?

You can purchase shares of CytomX Therapeutics (NASDAQ:CTMX) through any online brokerage.

View our list of the best stock brokerages

Who are CytomX Therapeutics (CTMX) competitors?

Other companies in CytomX Therapeutics’s space includes: Innate Pharma (NASDAQ:IPHA), Voyager Therapeutics (NASDAQ:VYGR), Tevogen Bio Holdings (NASDAQ:TVGN), Eledon Pharmaceuticals (NASDAQ:ELDN) and Anika Therapeutics (NASDAQ:ANIK).

What is the forecast, or price target, for CytomX Therapeutics (CTMX) stock?

CytomX Therapeutics has a consensus price target of $5.07.

What is the current price for CytomX Therapeutics (CTMX)?

The stock price for CytomX Therapeutics (NASDAQ: CTMX) is $2.15 last updated May 15, 2025 at 11:36 AM EDT.

Does CytomX Therapeutics (CTMX) pay a dividend?

There are no upcoming dividends for CytomX Therapeutics.

When is CytomX Therapeutics (NASDAQ:CTMX) reporting earnings?

CytomX Therapeutics’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is CytomX Therapeutics (CTMX) going to split?

There is no upcoming split for CytomX Therapeutics.

What sector and industry does CytomX Therapeutics (CTMX) operate in?

CytomX Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.